Free Trial

Yorktown Management & Research Co Inc Acquires Shares of 17,900 Afya Limited (NASDAQ:AFYA)

Afya logo with Consumer Discretionary background

Yorktown Management & Research Co Inc purchased a new stake in Afya Limited (NASDAQ:AFYA - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 17,900 shares of the company's stock, valued at approximately $321,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Public Employees Retirement System of Ohio raised its stake in Afya by 40.0% in the fourth quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company's stock valued at $44,000 after buying an additional 800 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Afya by 1,099.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock worth $64,000 after purchasing an additional 3,695 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Afya by 2,115.9% during the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock worth $106,000 after purchasing an additional 6,369 shares in the last quarter. Aquatic Capital Management LLC increased its position in shares of Afya by 47.6% during the fourth quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company's stock worth $148,000 after purchasing an additional 3,000 shares in the last quarter. Finally, Van ECK Associates Corp increased its position in shares of Afya by 41.9% during the fourth quarter. Van ECK Associates Corp now owns 9,677 shares of the company's stock worth $154,000 after purchasing an additional 2,856 shares in the last quarter. 88.02% of the stock is currently owned by institutional investors and hedge funds.

Afya Stock Performance

Shares of NASDAQ AFYA traded down $0.05 during midday trading on Friday, reaching $17.57. 39,521 shares of the company were exchanged, compared to its average volume of 122,534. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.41. Afya Limited has a 1 year low of $14.52 and a 1 year high of $19.90. The stock has a fifty day simple moving average of $18.46 and a 200 day simple moving average of $17.27. The stock has a market cap of $1.65 billion, a P/E ratio of 13.31, a PEG ratio of 0.60 and a beta of 0.60.

Analysts Set New Price Targets

A number of analysts have recently commented on AFYA shares. Morgan Stanley cut Afya from an "equal weight" rating to an "underweight" rating and cut their target price for the stock from $19.00 to $17.00 in a research report on Tuesday, March 11th. Wall Street Zen upgraded Afya from a "hold" rating to a "buy" rating in a research report on Saturday, June 14th. Finally, UBS Group reiterated a "neutral" rating and set a $19.50 target price (up previously from $17.50) on shares of Afya in a research report on Thursday, June 12th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $17.60.

Check Out Our Latest Research Report on AFYA

About Afya

(Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Recommended Stories

Institutional Ownership by Quarter for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential
Time to Cash Out? 5 Stocks to Drop Before Earnings

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines